Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07448974 · ClinicalTrials.gov registry record · Phase 3
Vitamin D and Type 2 Diabetes - Treat-To-Target
A Phase 3 study, sponsored by Tufts Medical Center.
- Not yet
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT07448974 is a Phase 3 study that has not yet begun recruiting, run by Tufts Medical Center. The registered enrollment target is 100 participants.
The verdict
NCT07448974, a Phase 3 study, has not yet begun recruiting, sponsored by Tufts Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study tests whether taking a weekly dose of vitamin D, with the dose adjusted to reach a target blood vitamin D level, can help control blood sugar levels in adults at high risk of developing type 2 diabetes (prediabetes). Research suggests that vitamin D may play a role in blood sugar control. The goal of this study is to see whether adjusting the dose of vitamin D to reach a specific blood vitamin D level improves blood sugar control compared with a placebo (a look-alike pill without vitamin D). One hundred adults aged 30 to 74 with prediabetes will take part. Participants will be randomly assigned (by chance) to receive either weekly vitamin D supplements or a placebo. Neither the participants nor the research team will know which group a participant is in during the study. Participants in the vitamin D group will start with one specific dose. After three months, a blood test will be used to decide whether the dose should stay the same or be increased to reach the target vitamin D level. Participants in the placebo group will continue taking the placebo each week. All participants will be followed for about 18 months. During the study, they will attend scheduled study visits, have blood tests, and wear a continuous glucose monitor, a small device that measures blood sugar levels throughout the day and night. The research team will also make periodic phone calls to check on health changes, medication use, and study participation. The main outcome of the study is the proportion of time that the participants' blood sugar levels remains in a healthy range.
Interventions
- DRUG Placebo
- DRUG Vitamin D (Cholecalciferol )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-05 |
| Est. Completion | 2031-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07448974
The ClinicalTrials.gov registry entry for NCT07448974 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07448974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07448974 about?
NCT07448974 is a clinical study titled "Vitamin D and Type 2 Diabetes - Treat-To-Target". This study tests whether taking a weekly dose of vitamin D, with the dose adjusted to reach a target blood vitamin D level, can help control blood sugar levels in adults at high risk of developing type 2 diabetes (prediabetes). Research suggests that vitamin D may play a role in blood sugar control...
What is the current status of trial NCT07448974?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2026-05. Estimated completion is 2031-03.
What interventions are being tested in trial NCT07448974?
The interventions under investigation include: Placebo (DRUG), Vitamin D (Cholecalciferol ) (DRUG).
Who is sponsoring clinical trial NCT07448974?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.